Reporting Quality Assessment of COVID-19 Clinical Trials in China at the beginning of the Pandemic: An Empirical Study based on the CONSORT Statement

Journal Title: Medical Journal of Clinical Trials & Case Studies - Year 2021, Vol 5, Issue 1

Abstract

Objectives: This study aimed to evaluate the reporting quality and risk of bias of Chinese COVID-19 RCTs. Methods: The Chinese clinical trial registry (ChiCTR) was searched for registered COVID-19 clinical trials before April 2, 2020. The reporting quality and risk of bias of included literatures were assessed using the Consolidating Standards of Reporting Trials 2010 (CONSORT 2010) and Cochrane risk of bias tool, respectively. Results: Of the 283 clinical trials identified, 172 RCTs were included. Some items including objectives, trial design, participants, interventions, outcomes and registration were presented in all RCTs, other items in limited RCTs, including blinding (11.63%), allocation concealment mechanism (14.53%), implementation (47.09%), title/abstract (54.07%), protocol (94.77%), sequence generation (97.09%), and funding (98.84%). The top three score among 25-item were background and objectives (10.00), registration (10.00) and funding (9.90), while the lowest four score all belonged to randomization part, including blinding (0.59), allocation concealment mechanism (0.88), implementation (1.43) and sequence generation (2.71). Among the RCTs, 75.58% showed low risk of bias in random sequence generation, while only 9.30% low risk of bias in allocation concealment. Besides, 39.53% presented with high performance bias and detection bias. Conclusions: The reporting quality of RCTs registered on the ChiCTR was significantly lower than expected, especially in randomization and blinding. Researchers are advised to refer to the CONSORT statement when designing a RCT.

Authors and Affiliations

Cui Z , Zhang Z , Bai Q and Bian Y*

Keywords

Related Articles

Treatment of Critical, Severe and Non-Severe COVID-19 by Corticosteroids

Glucocorticoids or corticosteroids have main anti-inflammatory effects to inhibit a vast number of pro-inflammatory genes that involve encoding of cell adhesion molecules, chemokines, cytokines, inflammatory receptors a...

An Overview of the Influence of Age and Experience on the Frequency of Compliance on the Use of Safety Eye Glass Wears by Welders on Duty in Abakaliki Metropolis

In this work, we considered the influence of age and years of experience of a welder on the job to the frequency of compliance to use of protective eyewear when on duty in Abakaliki metropolis. To get at this, well-struc...

Case Report Neonatal Stroke

Stroke is a brain injury caused by the interruption of blood -flowing to part of the brain. A neonatal stroke is a disturbance in the blood supply to an infant’s brain in the first 28 days of life [1]. This includes bot...

Two Rare Complications of Acute Bacterial Meningitis Subarachnoid Hemorrhage and Intraventricular Hemorrhage in a Single Frame: A Case Report

Meningitis can lead to severe and disabling neurological consequences if diagnosis and treatment is delayed. There are multiple complications associated with meningitis including cerebrovascular accidents. Subarachnoid h...

Clinical Picture of COVID19 in Indian Children, Rarity of COVID Toes or Hands

The incidence of Covid 19 affecting children and young adults has been around 1 to 2% of total cases

Download PDF file
  • EP ID EP756400
  • DOI 10.23880/mjccs-16000S1-010
  • Views 22
  • Downloads 0

How To Cite

Cui Z, Zhang Z, Bai Q and Bian Y* (2021). Reporting Quality Assessment of COVID-19 Clinical Trials in China at the beginning of the Pandemic: An Empirical Study based on the CONSORT Statement. Medical Journal of Clinical Trials & Case Studies, 5(1), -. https://www.europub.co.uk/articles/-A-756400